Grobio
5 known investors
GRObio (GRO Biosciences) develops protein therapeutics using non-standard amino acids (NSAAs) via its GRO platform, aiming to improve protein potency, stability, and function. Its pipeline is built on two NSAA chemistry families—DuraLogic for therapeutic stability and dosing, and ProGly for biologics addressing autoimmune disease and immunogenicity.
BiotechDeep TechHealthtech
Investors · 5
Frequently asked questions
- What does Grobio do?
- GRObio (GRO Biosciences) develops protein therapeutics using non-standard amino acids (NSAAs) via its GRO platform, aiming to improve protein potency, stability, and function. Its pipeline is built on two NSAA chemistry families—DuraLogic for therapeutic stability and dosing, and ProGly for biologics addressing autoimmune disease and immunogenicity.
- Who are Grobio's investors?
- Grobio's investors include Leaps by Bayer, REDMILE, Dreamers VC, Digitalis Ventures, OS Fund.